Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-11-000017)

Filing Details

Accession Number:: 0000711377-11-000017
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-03 11:48:51
Reporting Period:: 2011-05-03

Filing Date:: 2011-05-03
Accepted Time:: 2011-05-03 11:48:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189021	Edward Bradley		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-05-03	5,850	$9.02	115,370	No	4	M	Direct
Common Stock	Disposition	2011-05-03	5,850	$41.89	109,520	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Option (Right to Buy)	Disposition	2011-05-03	5,850	$0.00	5,850	$9.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
69,359		2011-11-03	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	14,012	Indirect	Held by Neogen 401k Plan

Footnotes

The options were granted 11/3/2006 as ISO options and became exercisable 20% yearly thereafter